Literature DB >> 7512033

Activation of CD4+ T cells by delivery of the B7 costimulatory signal on bystander antigen-presenting cells (trans-costimulation).

L Ding1, E M Shevach.   

Abstract

Increasing evidence in both murine and human systems suggests that the interaction of the T cell surface antigens CD28/CTLA4 with their ligand B7 on the antigen-presenting cells (APC) is the critical costimulatory pathway involved in the induction of maximal T cell activation and the prevention of induction of anergy. It has also been demonstrated that efficient induction of clonal expansion of normal CD4+ T cells requires the delivery of the T cell receptor (TCR) ligand and costimulation by the same APC. We demonstrate here that normal murine CD4+ T cells can be efficiently activated by soluble anti-CD3 cross-linked by fixed macrophages and by a costimulatory signal delivered by a bystander APC, B7-transfected L cells. The major factor which determined the ability of an APC to provide costimulation in "trans" was the level of cell surface B7 expression. The requirement for B7 costimulation appears to be at initial stage of TCR engagement since optimal T cell activation was only observed when TCR triggering and B7 costimulatory activity were delivered at same time by different APC. Induction of maximal proliferation of both naive CD45RBhi and memory CD45RBlo CD4+ T cells was B7 dependent and both populations of cells responded equally well to the B7 costimulation delivered in "trans". Furthermore, trans-costimulation provided by B7 transfected L cells efficiently prevented the induction of anergy in normal murine CD4+ T cells induced by anti-CD3 cross-linked by fixed-resting macrophages. Addition of exogenous interleukin-2 (IL-2) and IL-7 to the primary culture in the absence of B7-transfected L cells or addition of IL-2 to the culture containing the B7 transfectant and CTLA4Ig completely prevented the induction of hyporesponsiveness. These findings raise the possibility that in certain pathological states, CD4+ T cells in vivo may be activated by costimulation delivered by bystander APC.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7512033     DOI: 10.1002/eji.1830240413

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

1.  Induction of T cell anergy by liposomes with incorporated major histocompatibility complex (MHC) II/peptide complexes.

Authors:  A J van Rensen; L S Taams; M C Grosfeld-Stulemeyer; W van Eden; D J Crommelin; M H Wauben
Journal:  Pharm Res       Date:  2000-06       Impact factor: 4.200

Review 2.  CTLA-4 and tolerance: the biochemical point of view.

Authors:  Shunsuke Chikuma; Jeffrey A Bluestone
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

3.  CD80 cytoplasmic domain controls localization of CD28, CTLA-4, and protein kinase Ctheta in the immunological synapse.

Authors:  Su-Yi Tseng; Mengling Liu; Michael L Dustin
Journal:  J Immunol       Date:  2005-12-15       Impact factor: 5.422

4.  Cross talk between CD3 and CD28 is spatially modulated by protein lateral mobility.

Authors:  Keenan T Bashour; Jones Tsai; Keyue Shen; Joung-Hyun Lee; Eileen Sun; Michael C Milone; Michael L Dustin; Lance C Kam
Journal:  Mol Cell Biol       Date:  2013-12-30       Impact factor: 4.272

5.  Spontaneous allograft tolerance in B7-deficient mice independent of preexisting endogenous CD4+CD25+ regulatory T-cells.

Authors:  Todd J Grazia; Robert J Plenter; An N Doan; Brian P Kelly; Sarah M Weber; Jonathan S Kurche; Susan O Cushing; Ronald G Gill; Biagio A Pietra
Journal:  Transplantation       Date:  2007-06-15       Impact factor: 4.939

6.  Antigen presentation by keratinocytes directs autoimmune skin disease.

Authors:  Lian Fan; Brian W Busser; Traci Q Lifsted; Mohamed Oukka; David Lo; Terri M Laufer
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

7.  T cell apoptosis in human heart allografts: association with lack of co-stimulation?

Authors:  E Van Hoffen; D F Van Wichen; J C Leemans; R A Broekhuizen; A H Bruggink; M De Boer; N De Jonge; H Kirkels; P J Slootweg; F H Gmelig-Meyling; R A De Weger
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

8.  Mechanisms of ganglioside inhibition of APC function.

Authors:  Sheila Caldwell; Andreas Heitger; Weiping Shen; Yihui Liu; Barbara Taylor; Stephan Ladisch
Journal:  J Immunol       Date:  2003-08-15       Impact factor: 5.422

9.  Keratinocyte expression of B7-1 in transgenic mice amplifies the primary immune response to cutaneous antigens.

Authors:  I R Williams; R J Ort; T S Kupper
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

Review 10.  Immune checkpoint proteins: exploring their therapeutic potential to regulate atherosclerosis.

Authors:  A C Foks; J Kuiper
Journal:  Br J Pharmacol       Date:  2017-05-04       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.